Relatório global de análise do tamanho, quota e tendências do mercado de administração de medicamentos tópicos – Visão geral do setor e previsão para 2031

Pedido de resumo Pedido de TOC Fale com Analista Fale com o analista  Comprar agora Comprar agora Consulte antes Comprar Consulte antes Relatório de amostra grátis Relatório de amostra grátis

Relatório global de análise do tamanho, quota e tendências do mercado de administração de medicamentos tópicos – Visão geral do setor e previsão para 2031

  • Healthcare
  • Upcoming Reports
  • Sep 2024
  • Global
  • 350 Páginas
  • Número de tabelas: 220
  • Número de figuras: 60

Global Topical Drug Delivery Market

Tamanho do mercado em biliões de dólares

CAGR :  % Diagram

Diagram Período de previsão
2024 –2031
Diagram Tamanho do mercado (ano base )
USD 116.30 Billion
Diagram Tamanho do mercado ( Ano de previsão)
USD 198.33 Billion
Diagram CAGR
%
Diagram Principais participantes do mercado
  • Johnson & Johnson Private Limited
  • Nestlé India
  • Novartis AG
  • GlaxoSmithKline plc
  • Bausch Health Companies

>Segmentação global do mercado de administração de medicamentos tópicos, por produto (formulações semi-sólidas, formulações líquidas, formulações sólidas, produtos transdérmicos), via de administração (entrega de medicamentos dérmicos, administração de medicamentos oftálmicos, administração de medicamentos retais, administração de medicamentos vaginais, entrega de medicamentos nasais), Canal de Distribuição (Concursos Directos, Retalho), Utilizador Final (Hospitais, Clínicas, Cuidados Domiciliários, Centros de Diagnóstico, Outros) – Tendências e Previsões do Sector para 2031.

Mercado tópico de administração de medicamentos

Análise tópica do mercado de administração de medicamentos

De acordo com um estudo intitulado “Epidemiologia nacional, regional e mundial da psoríase”, em maio de 2020, a incidência de psoríase em adultos foi prevista em cerca de 30,3 por 100.000 pessoas-ano em Taiwan e cerca de 321,0 por 100.000 pessoas-ano em Itália. A prevalência das doenças de pele está a aumentar a um ritmo mais rápido e está a tornar-se um problema global. A enorme carga associada às diversas doenças e condições de pele torna a administração de medicamentos altamente crucial, razão pela qual o mercado de distribuição tópica de medicamentos é impactado positivamente pelo aumento da prevalência de doenças de pele. Como resultado, estima-se que o mercado apresente um crescimento rentável durante o período previsto.

Tamanho do mercado de administração de medicamentos tópicos

O tamanho global do mercado de administração de medicamentos tópicos foi avaliado em 116,30 mil milhões de dólares em 2023 e deverá atingir 198,33 mil milhões de dólares até 2031, com um CAGR de 6,9% durante o período de previsão de 2024 a 2031 .

Âmbito do relatório e segmentação de mercado       

Atributos

Principais insights do mercado de administração de medicamentos tópicos

Segmentação

  • Por Produto : Formulações Semi-sólidas, Formulações Líquidas, Formulações Sólidas, Produtos Transdérmicos
  • Por via de administração : administração dérmica de medicamentos, administração oftálmica de medicamentos, administração rectal de medicamentos, administração vaginal de medicamentos, administração nasal de medicamentos
  • Por Canal de Distribuição : Concursos Directos, Retalho
  • Por utilizador final : hospitais, clínicas, assistência médica domiciliária , centros de diagnóstico, outros

Países abrangidos

EUA, Canadá, México, Alemanha, Itália, Reino Unido, França, Espanha, Holanda, Bélgica, Suíça, Turquia, Rússia, Resto da Europa, Japão, China, Índia, Coreia do Sul, Austrália, Singapura, Malásia, Tailândia, Indonésia , Filipinas , Resto da Ásia-Pacífico, Brasil, Argentina, Resto da América do Sul, África do Sul, Arábia Saudita, Emirados Árabes Unidos, Egito, Israel, Resto do Médio Oriente e África

Principais participantes do mercado

Johnson & Johnson Private Limited (U.S.), Nestlé India Ltd.(Switzerland), Novartis AG (Switzerland), GlaxoSmithKline plc(U.K), Bausch Health Companies Inc., (Canada), Merck & Co Inc., (U.S.), Bayer AG (Germany), Hisamitsu Pharmaceutical Co.,Inc. (Japan), Glenmark Pharmaceuticals Limited, (India), Cipla Inc., (India), Crescita Therapeutics (Canada), Mylan N.V. (U.S.), Encore Dermatology, (U.S.), LEO Pharma A/S (Denmark), Almirall, S.A (Spain), Aclaris Therapeutics, Inc. (U.S.), Taro Pharmaceutical Industries Ltd. (U.S.), Teligent (U.S.), Perrigo Company plc (U.S.), Allergan (Ireland), Biofrontera, AG (U.S.), Crown (U.S.),  Akorn Operating Company LLC. (U.S.), Ingenus (U.S.), and Sun Pharmaceutical Industries Ltd. (India)

Market Opportunities

  • Rising rate of blood donations
  • Growing number of product approvals for skin-related drug delivery systems
  • Surge in demand for self-administration and home care

Topical Drug Delivery Market Definition

The topical medication delivery is recognized to be one of the most effective methods of drug delivery owing to its optimal therapeutic benefits. The desired therapeutic effect and the unwanted adverse effect of a medicine are both determined by the drug's concentration at the site of action. The medicine's concentration is determined by the dosage form and the extent of drug absorption at the site of action.

Topical Drug Delivery Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

Drivers

  • Increasing Incidences Of Targeted Diseases

The increasing incidences of skin infections such as eczema, psoriasis, and minor ailments including acne are the most significant factors driving the growth for this market. Moreover, the increasing incidences of burn injuries, prevalence of diabetes and eye diseases, and the extensive use of the drugs to treat diabetic neuropathic pain and foot ulcers are also expected to accelerate the market's overall growth.

  • Benefits of Transdermal Route

One of the emerging trends in the topical drug delivery market is the delivery of biologics through the transdermal route. The use of transdermal delivery of big molecules offers considerable patient benefits such as painless medication delivery and cost-effective treatment. This factor is projected to bolster the growth of the market.

Furthermore, the preference towards administration of drugs through the skin to control or prolong drug delivery and the use of this process as an alternative to the oral route are also expected to fuel market growth. Moreover, the system's ease of use combined with the increasing requirement for self-administered drugs also cushions the market's growth within the forecasted period.

Opportunities

  • Growing Approvals And Self-Administration

Moreover, the rise in demand for self-administration and home care and rising rate of blood donations are estimated to generate lucrative opportunities for the market. The growing number of product approvals for skin-related drug delivery systems will further offer numerous growth opportunities for the market.

Restraints/Challenges 

  • Availability of Alternatives

There are various alternative drug delivery modes available for the patients. The preference for alternative modes of drug delivery and product recalls due to drug failure is expected to obstruct market growth.

  • Technical Barriers

Also, the technical barriers associated with the skin irritation and permeability are projected to challenge the topical drug delivery market in the forecast period of 2024-2031.

This topical drug delivery market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the topical drug delivery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Post Covid-19 Impact on Topical Drug Delivery Market

The topical drug delivery market was largely impacted by the outbreak of COVID-19. The imposition of the social distancing and travel restrictions by the government to curb the COVID-19 pandemic outbreak, led to halt of various operations which led to emergence of various challenges, such as supply chain disruptions, stifling business growth, suspensions of new developments, temporary lockout of production sites in locations and has affected the overall production and sales. Moreover, the raw materials essential for making medications (such as drug and manufacturing equipment) are at risk of a supply shortage, leading to limited industry expansion.

On the brighter side, the global economy is predicted to gradually normalize, with an increase in the manufacturing and transportation of raw materials and associated equipment, resulting in market growth. As a result of the alarming increase in COVID-19 cases, there is a greater need for enhanced patient treatment, and the use of medications like vitamin C, multivitamins, and antivirals to boost immune levels has increased. Also, the drugs are being stored by various end users and patients due to COVID-19's rapid expansion and rising panic. This is likely to improve the topical medication delivery market's growth. Various companies had a rise in sales. AbbVie, for example, saw a 16.8 percent gain in sales over this time period. Similarly, Amgen reported sales of USD 6,161 million in the first quarter of 2020, up 11% from the first quarter of 2019. (USD 5,286 million).

Topical Drug Delivery Market Scope

The topical drug delivery market is segmented on the basis of product, route of administration, distribution channel and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Semi-Solid Formulations
  • Liquid Formulations
  • Solid Formulations
  • Transdermal Products

On the basis of product, the topical drug delivery market is segmented into semi-solid formulations, liquid formulations, solid formulations and transdermal products. Semi-solid formulations are further segmented into creams, ointments, lotions, gels and pastes. Liquid formulations are further segmented into solutions and suspensions. Solid formulations are further segmented into powders and suppositories. Transdermal products are further segmented into transdermal patches and transdermal semi-solids. The semi-solid formulations registers the largest market share owing to the easy application of semi-solid formulations along with their ability to deliver a wide variety of drug molecules, which leads to high demand for it among end users.

Route of Administration

  • Dermal Drug Delivery
  • Ophthalmic Drug Delivery
  • Rectal Drug Delivery
  • Vaginal Drug Delivery
  • Nasal Drug Delivery

On the basis of route of administration, the topical drug delivery market is segmented into dermal drug delivery, ophthalmic drug delivery, rectal drug delivery, vaginal drug delivery and nasal drug delivery.

Distribution Channel

  • Direct Tenders
  • Retail

On the basis of distribution channel, the topical drug delivery market is segmented into direct tenders and retail.

End User

  • Hospitals
  • Clinics
  • Home Healthcare
  • Diagnostic Centers
  • Others

On the basis of end user, the topical drug delivery market is bifurcated into hospitals, clinics, home healthcare, diagnostic centers and others.

Topical Drug Delivery Market Regional Analysis

The topical drug delivery market is analyzed and market size insights and trends are provided by country, product, route of administration, distribution channel and end user as referenced above.

The countries covered in the topical drug delivery market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the topical drug delivery market because of the presence of large number of pharmaceutical companies and drug delivery technology providers within the region.

Asia-Pacific is expected to witness significant growth during the forecast period of 2024 to 2031 due to the surge in geriatric population and the surge in disposable income of the people within the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The topical drug delivery market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for topical drug delivery market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the topical drug delivery market. The data is available for historic period 2010-2020.

Topical Drug Delivery Market Share

The topical drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to topical drug delivery market.

Topical Drug Delivery Market Leaders Operating in the Market Are:

  • Johnson & Johnson Private Limited (EUA)
  • Nestlé India Ltd., (Suíça)
  • Novartis AG (Suíça)
  • GlaxoSmithKline plc (Reino Unido)
  • Bausch Health Companies Inc., (Canadá)
  • Merck & Co Inc., (EUA)
  • Bayer AG (Alemanha),
  • Hisamitsu Pharmaceutical Co., Inc. (Japão)
  • Glenmark Pharmaceuticals Limited, (Índia)
  • Cipla Inc., (Índia)
  • Crescita Therapeutics (Canadá)
  • Mylan NV (EUA)
  • Encore Dermatologia, (EUA)
  • LEO Pharma A/S (Dinamarca)
  • Almirall, SA (Espanha)
  • (EUA)
  • Taro Pharmaceutical Industries Ltd.
  • Teligent (EUA), Perrigo Company plc (EUA)
  • Allergan (Irlanda)
  • Biofrontera, AG (EUA)
  • Coroa (EUA)
  • Akorn Operating Company LLC. (NÓS)
  • Ingenus (EUA)
  • Sun Pharmaceutical Industries Ltd. (Índia)

Últimos desenvolvimentos no mercado de administração de medicamentos tópicos

  • Em fevereiro de 2021, a Almirall SA, uma empresa biofarmacêutica mundial pioneira num novo padrão em medicamentos tópicos para doenças autoimunes e inflamatórias crónicas, anunciou que a MC2 Therapeutics concedeu à Almirall direitos europeus exclusivos para comercializar o creme Wynzora® para a terapia da psoríase em placas. Em troca, a MC2 Therapeutics será elegível para um pagamento inicial de 15 milhões de euros, bem como para pagamentos significativos por marcos de vendas e royalties de dois dígitos sobre as vendas do Wynzora Cream na Europa.


SKU-

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

  • Painel interativo de análise de dados
  • Painel de análise da empresa para oportunidades de elevado potencial de crescimento
  • Acesso de analista de pesquisa para personalização e customização. consultas
  • Análise da concorrência com painel interativo
  • Últimas notícias, atualizações e atualizações Análise de tendências
  • Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Pedido de demonstração

Metodologia de Investigação

A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados ​​e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.

A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis ​​de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.

Personalização disponível

A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.

Perguntas frequentes

The market is segmented based on Segmentation, By Product (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Products), Route of Administration (Dermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, Nasal Drug Delivery), Distribution Channel (Direct Tenders, Retail), End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others) – Industry Trends and Forecast to 2031. .
The Global Topical Drug Delivery Market size was valued at USD 116.30 USD Billion in 2023.
The Global Topical Drug Delivery Market is projected to grow at a CAGR of 6.9% during the forecast period of 2024 to 2031.
The major players operating in the market include , Johnson & Johnson Private Limited , Nestlé India , Novartis AG , GlaxoSmithKline plc , Bausch Health Companies , Merck & Co , Bayer AG , Hisamitsu Pharmaceutical Co. , Glenmark Pharmaceuticals Limited , Cipla , Crescita Therapeutics , Mylan N.V. , Encore Dermatology , LEO Pharma A/S , Almirall S.A , Aclaris Therapeutics , Taro Pharmaceutical Industries , Teligent , Perrigo Company plc , Allergan , Biofrontera AG , Crown , Akorn Operating Company LLC. , Ingenus , Sun Pharmaceutical Industries ,.
The market report covers data from the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa.